These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2188824)

  • 21. [Spirapril - a new long-acting ACE inhibitor: efficacy and safety in patients with arterial hypertension in combination with diabetes mellitus and impaired kidney function].
    Iakusevich VV; Mozheĭko ME; Paliutin ShKh; Berezina MIu; Martsevich SIu; Shal'nova SA; Deev AD; Kutishenko NP; Alimova EV; Koniakhina IP; Semenova IuE
    Ter Arkh; 2000; 72(10):82-6. PubMed ID: 11220887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension.
    Estacio RO; Jeffers BW; Hiatt WR; Biggerstaff SL; Gifford N; Schrier RW
    N Engl J Med; 1998 Mar; 338(10):645-52. PubMed ID: 9486993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.
    Chan JC; Ko GT; Leung DH; Cheung RC; Cheung MY; So WY; Swaminathan R; Nicholls MG; Critchley JA; Cockram CS
    Kidney Int; 2000 Feb; 57(2):590-600. PubMed ID: 10652036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crossover comparison of the effects of enalapril and captopril on potassium homeostasis in patients with mild hypertension.
    Ohya Y; Ueno M; Takata Y; Tominaga M; Ohmori S; Kobayashi K; Abe I; Fujishima M
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):655-9. PubMed ID: 7881704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does lipophilicity of angiotensin converting enzyme inhibitors selectively influence autonomic neural function in human hypertension?
    Wu RA; Kailasam MT; Cervenka JH; Parmer RJ; Kennedy BP; Ziegler MG; O'Connor DT
    J Hypertens; 1994 Nov; 12(11):1243-7. PubMed ID: 7868871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enalapril and atenolol in primary hypertension--a comparative study of blood pressure lowering and hormonal effects.
    Ohman KP; Karlberg BE
    Scand J Urol Nephrol Suppl; 1984; 79():93-7. PubMed ID: 6089325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE; Gillespie JB
    Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.
    Andersen S; Tarnow L; Rossing P; Hansen BV; Parving HH
    Kidney Int; 2000 Feb; 57(2):601-6. PubMed ID: 10652037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Urinary albumin excretion in non-insulin-dependent diabetic patients. Effects of an angiotensin-converting enzyme inhibitor].
    Durruty P; Tapia JC; Ugarte C; Pérez E; Krause P; Soto N; García de los Ríos M
    Rev Med Chil; 1996 Sep; 124(9):1036-44. PubMed ID: 9197016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Equivalent reduction of proteinuria in hypertensives by either nifedipine GITS or enalapril: disparate effects on neurohormones and ambulatory blood pressure and the influence of salt.
    DeQuattro V; Lee DP
    Cardiology; 1997; 88 Suppl 3():38-42. PubMed ID: 9397292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced pressor responsiveness to norepinephrine in type II diabetes. Effect of ACE inhibition.
    Ciavarella A; Mustacchio A; Ricci C; Capelli M; Vannini P
    Diabetes Care; 1994 Dec; 17(12):1484-7. PubMed ID: 7882823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beneficial effects of angiotensin-converting enzyme inhibitor on renal function and glucose homeostasis in diabetics with hypertension.
    Ueda Y; Aoi W; Yamachika S; Shikaya T
    Nephron; 1990; 55 Suppl 1():85-9. PubMed ID: 2189076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antihypertensive activity of enalapril. Effect of ibuprofen and different salt intakes.
    Minuz P; Lechi A; Arosio E; Degan M; Capuzzo MG; Lechi C; Corsato M; Dalla Riva A; Velo GP
    J Clin Hypertens; 1987 Dec; 3(4):645-53. PubMed ID: 2839629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antihypertensive therapy with Ca2+. Antagonist verapamil and/or ACE inhibitor enalapril in NIDDM patients.
    Ferrier C; Ferrari P; Weidmann P; Keller U; Beretta-Piccoli C; Riesen WF
    Diabetes Care; 1991 Oct; 14(10):911-4. PubMed ID: 1773691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension.
    Jackson B; Cubela R; Johnston CI
    J Hypertens; 1984 Aug; 2(4):371-7. PubMed ID: 6099390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ambulatory monitoring of arterial pressure in the treatment of mild-moderate arterial hypertension with lisinopril vs. enalapril].
    Motero Carrasco J
    Arch Inst Cardiol Mex; 1997; 67(1):29-37. PubMed ID: 9221708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of indapamide SR on microalbuminuria--the NESTOR study (Natrilix SR versus Enalapril Study in Type 2 diabetic hypertensives with micrOalbuminuRia)--rationale and protocol for the main trial.
    Marre M; Garcia Puig J; Kokot F; Fernandez M; Jermendy G; Opie L; Moyseev V; Scheen A; Ionescu-Tirgoviste C; Saldanha MH; Halabe A; Williams B; Mion D; Ruiz M; Hermansen K; Tuomilehto J; Finizola B; Pozza G; Chastang C; Ollivier JP; Amouyel P; Asmar R
    J Hypertens Suppl; 2003 Mar; 21(1):S19-24. PubMed ID: 12769163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enalaprilat: an intravenous substitute for oral enalapril therapy. Humoral and pharmacokinetic effects.
    Reams GP; Lal SM; Whalen JJ; Bauer JH
    J Clin Hypertens; 1986 Sep; 2(3):245-53. PubMed ID: 3023555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of enalapril in insulin-dependent diabetic subjects with mild to moderate uncomplicated hypertension.
    Passa P; LeBlanc H; Marre M
    Diabetes Care; 1987; 10(2):200-4. PubMed ID: 3034532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.
    Tylicki L; Rutkowski P; Renke M; Rutkowski B
    Am J Nephrol; 2002; 22(4):356-62. PubMed ID: 12169868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.